Forecast underlying FY16 EBITDA 270 - 290m.
1H16 underlying EBITDA 124.7m
Using middle estimate of 280m that leaves 155.3m for 2H16. That's a full 24.5% HIGHER than the already exceptional 1H16.
Plus the company forecast for FY17 is better again. By then debt will be significantly lower and even more goes to the bottom line i.e. eps. No guarantee, but new TO from another company wouldn't surprise. BRS is back in spades.
BRS Price at posting:
$1.14 Sentiment: Buy Disclosure: Held
